Paul van der Horst
Presidente en MOLECURE S.A. .
Perfil
Paul van der Horst is currently the Chairman-Supervisory Board at Molecure SA, the Director at Immunetune, and the Chief Business Officer at AgomAb Therapeutics NV.
Previously, he worked as the Director of Business Development & IR at Galapagos NV and as an Analyst at Van Lanschot Kempen NV (Broker).
He holds a doctorate degree from Erasmus University Rotterdam.
Cargos activos de Paul van der Horst
| Empresas | Cargo | Inicio |
|---|---|---|
| MOLECURE S.A. | Presidente | - |
AgomAb Therapeutics NV
 AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Corporate Officer/Principal | - |
| Immunetune | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Paul van der Horst.
| Empresas | Cargo | Fin |
|---|---|---|
| GALAPAGOS NV | Public Communications Contact | 01/04/2021 |
Van Lanschot Kempen NV (Broker)
 Van Lanschot Kempen NV (Broker) Investment Banks/BrokersFinance Van Lanschot Kempen NV (Broker) (Van Lanschot Kempen-Broker) is the broker-dealer division of Van Lanschot Kempen NV (AMS: VLK), a financial institution headquartered in Amsterdam, Netherlands. The firm was founded in 1903 and formerly known as Kempen & Co. NV. Van Lanschot Kempen-Broker provides securities broking to institutional investors, companies, financial institutions, (semi) public institutions, foundations and high net-worth individual clients. | Analyst-Equity | - |
Formación de Paul van der Horst.
| Erasmus University Rotterdam | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| GALAPAGOS NV | Health Technology |
| MOLECURE S.A. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Van Lanschot Kempen NV (Broker)
Van Lanschot Kempen NV (Broker) Investment Banks/BrokersFinance Van Lanschot Kempen NV (Broker) (Van Lanschot Kempen-Broker) is the broker-dealer division of Van Lanschot Kempen NV (AMS: VLK), a financial institution headquartered in Amsterdam, Netherlands. The firm was founded in 1903 and formerly known as Kempen & Co. NV. Van Lanschot Kempen-Broker provides securities broking to institutional investors, companies, financial institutions, (semi) public institutions, foundations and high net-worth individual clients. | Finance |
AgomAb Therapeutics NV
AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Commercial Services |
| Immunetune |
- Bolsa de valores
- Insiders
- Paul van der Horst
